Difference between revisions of "The Compendium of Cancer Genome Aberrations"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][checked revision]
(16 intermediate revisions by one other user not shown)
Line 12: Line 12:
 
{{Box-round|title=Newest Items|titlebackground=#06B5AD|Explore the great content available in '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', '''<u>[[Myelodysplastic Syndromes (MDS)|Myelodysplastic Syndromes (MDS)]]</u>''', '''<u>[[Myeloproliferative Neoplasms (MPN)|Myeloproliferative Neoplasms (MPN)]]</u>''', and '''<u>[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)]]</u>'''.
 
{{Box-round|title=Newest Items|titlebackground=#06B5AD|Explore the great content available in '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', '''<u>[[Myelodysplastic Syndromes (MDS)|Myelodysplastic Syndromes (MDS)]]</u>''', '''<u>[[Myeloproliferative Neoplasms (MPN)|Myeloproliferative Neoplasms (MPN)]]</u>''', and '''<u>[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)]]</u>'''.
 
}}
 
}}
−
<br />
+
<br />  
 
<inputbox>
 
<inputbox>
 
type=search2
 
type=search2
Line 46: Line 46:
 
<br>
 
<br>
 
<br>
 
<br>
−
[[File:CGC logo only.png|100px|link=Main_Page]] '''CGC Workgroups Recurrent Loci Tables''' [[AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|AML]] | [[MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray|MDS/MPN]] | [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH|CLL]] | [[Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray|CNS Tumors]] | [[Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations|Plasma Cell Neoplasms]] | [[Breast Cancer Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|Breast Cancer]] | [[Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations|Renal Neoplasia]]
+
[[File:CGC logo only.png|100px|link=Main_Page]]<span id="fp-span-cgc-pre"> '''CGC Workgroups Recurrent Loci Tables'''</span><span id="fp-span-cgc" style="display: block; margin-top: -62px; margin-left: 385px;"> [[AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|AML]] | [[MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray|MDS/MPN]] | [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH|CLL]] | [[Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray|CNS Tumors]] | [[Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations|Plasma Cell Neoplasms]] | [[Breast Cancer Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|Breast Cancer]] | [[Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations|Renal Neoplasia]] | [[B-ALL Tables: Prognostic Genomic Abnormalities and Recurrent Gene Fusions|B-ALL]]</span>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<div style="clear: both;"></div>
 
<div style="clear: both;"></div>
−
<div style="margin: auto;">
+
<div id="bottom-fp-links" style="margin: auto;">
 
<div style="height:150px;">
 
<div style="height:150px;">
−
<div style="width: 24%; float: left;">
+
<div class="bottom-fp-links-column" style="width: 24%; float: left;">
 
<div style="float: left; padding-right: 10px; height: 150px;">
 
<div style="float: left; padding-right: 10px; height: 150px;">
 
[[File:Plus2.png|30px|link=About]]
 
[[File:Plus2.png|30px|link=About]]
Line 66: Line 66:
 
</div>
 
</div>
 
</div>
 
</div>
−
<div style="width: 24%; float: left;">
+
<div class="bottom-fp-links-column" style="width: 24%; float: left;">
 
<div style="float: left; padding-right: 10px; height: 150px;">
 
<div style="float: left; padding-right: 10px; height: 150px;">
 
[[File:Star.png|45px|link=About]]
 
[[File:Star.png|45px|link=About]]
Line 82: Line 82:
 
</div>
 
</div>
 
</div>
 
</div>
−
<div style="width: 24%; float: left;">
+
<div class="bottom-fp-links-column" style="width: 24%; float: left;">
 
<div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;">
 
<div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;">
 
[[File:Arrow.png|30px|link=About]]
 
[[File:Arrow.png|30px|link=About]]
Line 92: Line 92:
 
</div>
 
</div>
 
</div>
 
</div>
−
                 <div style="width: 24%; float: left;">
+
                 <div class="bottom-fp-links-column" style="width: 24%; float: left;">
 
<div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;">
 
<div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;">
 
[[File:Ask.png|30px|link=About]]
 
[[File:Ask.png|30px|link=About]]

Revision as of 10:52, 26 July 2021

Welcome to the Compendium of Cancer Genome Aberrations (CCGA)! The CCGA is a collaborative effort to document and describe chromosome and other genomic abnormalities in cancer structured based on current WHO classification. The Wiki style interface allows for real-time editing and content sharing within our genetics community. This resource is sponsored and supported by the Cancer Genomics Consortium (CGC) and contributed to by colleagues with an interest in clinical cytogenetics, molecular genetics and genomics in cancer.

  • Join the CCGA community! If you would like to contribute as an author, please complete a few brief questions on our Volunteer Form.
  • Contact us for more information or suggestions for updates.
  • For contributors, we've created a Video Tutorial demonstrating how to add content to the CCGA. Please also refer to helpful Author Instructions.
  • Become a part of our Twitter family for the latest updates @ccgawiki.
editNewest Items
Explore the great content available in Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN), and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN).


 
Search content structured based on the WHO Classification (click book image). Reference: World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. IARC Press: Lyon, France, 2017. The hierarchical tumour classification structure is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.


Inv 16 pathology.png Diseases A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Example translocation.png Structural Abnormalities 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | X | Y


Fish zoomed.png Cancer Genes A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Circos.png Cancer Genomes Hematologic and Lymphoid | Solid Tumors | CNS | Pediatric

CGC logo only.png CGC Workgroups Recurrent Loci Tables AML | MDS/MPN | CLL | CNS Tumors | Plasma Cell Neoplasms | Breast Cancer | Renal Neoplasia | B-ALL



Notice and Disclaimer/Limitation of Liability of Resource Use

Data and information obtained from the Cancer Genomics Consortium (CGC) and the Compendium of Cancer Genome Aberrations (CCGA) is provided as an educational resource only. These data are provided on an "AS IS" basis, without representation or warranty of any kind, including without limitation the warranties of merchantability, fitness for a particular purpose and non-infringement. Availability of this data and information does not constitute scientific publication. Data and/or information may contain errors or be incomplete.

The CGC, CCGA and all participating entities make no representation or warranty, express or implied, including without limitation any warranties of merchantability or fitness for a particular purpose or warranties as to the identity or ownership of data or information, the quality, accuracy or completeness of data or information, or that the use of such data or information will not infringe any patent, intellectual property or proprietary rights of any party.

The CGC and CCGA shall not be liable for any claim for any and all loss, harm, illness or other damage or injury arising from access to or use of data or information howsoever caused, including without limitation, any direct, indirect, incidental, exemplary, special or consequential damages, even if advised of the possibility of such damages. The data and information obtained from the Cytogenomics Array Group database shall not be used as a substitute for the user's skills, expertise and experience.



Retrieved from "https://ccga.io/index.php?title=The_Compendium_of_Cancer_Genome_Aberrations&oldid=10355"